AstraZeneca builds in China as Cosette buys Mayne

The week has ended with a flurry of M&A in the drug industry, with Cosette Pharmaceuticals agreeing to buy Australia's Mayne Pharma and AstraZeneca buying the Chinese subsidiary of FibroGen.